openPR Logo
Press release

Artificial Heart-Lung Machine Market – Expected to Propel Market in the Future by Key Player: Medtronic, Sorin Group, MAQUET, Terumo Corporation, C. R. Bard and More

03-18-2019 11:05 AM CET | Health & Medicine

Press release from: Allied Market Research

Artificial Heart-Lung Machine Market

Artificial Heart-Lung Machine Market

Rise in the prevalence of heart diseases, awareness about cardiovascular devices, and growth in geriatric population are expected to drive the market growth. In addition, technological advancements and improvement in healthcare facilities will fuel the market growth.

Key players profiled in the report are Medtronic Inc., Sorin Group, MAQUET GmbH & Co. KG, Terumo Corporation, C. R. Bard Inc., Edwards Lifesciences, Braile Biomedica, Tianjin Medical, SynCardia, Jarvik Heart.

Get Sample PDF Brochure of Artificial Heart-Lung Machine Market Study at: https://www.alliedmarketresearch.com/request-toc-and-sample/3350

An artificial heart-lung machine is used in open heart surgeries to support the proper functioning of the heart and body during the surgery. The heart-lung machine consists of a chamber that receives blood from the body, oxygenates the blood, and transfers it to all parts of the body. This machine is connected to the patient with a series of tubes, which is removed after the completion of the surgery when the heart and lungs resume its functions.

However, factors such as stringent government regulations and dearth of skilled professionals are expected to restrain the market growth. Increase in government investments in the healthcare sector is expected to offer new opportunities during the analysis period.

The artificial heart-lung machine market is segmented based on type, application, and geography. Based on type the market is segmented into single roller pump, and double roller pump. By application, the market is classified into cardiac surgery, lung transplantation operations, acute respiratory failure treatment, and others. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The study provides an in-depth analysis of the global artificial heart-lung machine market, with current trends and future estimations to elucidate investment pockets.Comprehensive analysis of factors that drive and restrict the growth of the market has been provided. The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities. Extensive analysis of different segments determines various products that are available in the market. Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Buy now at: https://www.alliedmarketresearch.com/checkout/476796

Artificial Heart-lung Machine Market Key Segments:

By Type

• Single Roller Pump
• Double Roller Pump

By Application

• Cardiac Surgery
• Lung Transplantation Operations
• Acute Respiratory Failure Treatment
• Others

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Heart-Lung Machine Market – Expected to Propel Market in the Future by Key Player: Medtronic, Sorin Group, MAQUET, Terumo Corporation, C. R. Bard and More here

News-ID: 1659130 • Views: 342

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Heart

Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing